Drug Profile
Omega-3 fatty acid/rosuvastatin - Kuhnil Pharmaceutical Company
Alternative Names: KI-1107; ROSUMEGALatest Information Update: 27 Oct 2020
Price :
$50
*
At a glance
- Originator Kuhnil Pharmaceutical Company
- Class Antihyperlipidaemics; Fluorobenzenes; Omega 3 fatty acids; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Dyslipidaemias